Bioactive Compounds
-
N1622 Panaxadiol -
BA1843 TiviciclovirSummary: An antiviral guanosine analog and a hepatitis B virus inhibitor. -
N1441 Fraxinellone -
BA1842 AlamifovirSummary: Alamifovir (LY582563; MCC-478) is a purine nucleotide analog precursor that shows potent activity against wild-type and lamivudine-resistant hepatitis B virus. -
BA2996 UC-514321Summary: A selective TET1 inhibitor -
BA1841 BA-53038BSummary: BA-53038B is a core protein alteration modulator (CpAM) that binds to the HAP pocket and regulates coat assembly. -
BA1840 InarigivirSummary: Inarigivir (ORI-9020; SB-9000) is a dinucleotide antiviral compound that significantly reduces DNA in transgenic mice expressing hepatitis B virus. -
BA1839 FNC-TPSummary: FNC-TP is the intracellular active form of FNC. -
C8447 TNF-α-IN-1 -
BA1838 TorcitabineSummary: Torcitabine (2'-Deoxy-L-cytidine) is an antivirally active molecule.

